Clinical Trial Update: Efficacy Study of Subcutaneous Methyl-B12 in Children With Autism [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update reports on efficacy testing of subcutaneous methyl-B12 in children with autistic disorder, spanning Phase 2 and Phase 3 and completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autistic Disorder

Drugs mentioned

• Methyl B12 (methylcobalamin)

Snippet

Sponsor: University of California, San Francisco | Conditions: Autistic Disorder | Phase 2, Phase 3 | Status: COMPLETED